JARED SCHIEFER: Open Payments
NPI 1548881196 · COLUMBIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 46 payments from 19 companies in 2025. Trend: 2023 $4,292 · 2024 $3,788 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $178 |
| AstraZeneca Pharmaceuticals LP | 6 | $160 |
| Lilly USA, LLC | 4 | $67 |
| Novo Nordisk Inc | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Amgen Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
Products named: AIRSUPRA, VRAYLAR, MOUNJARO, REXULTI, SPRAVATO, XIFAXAN, QULIPTA, CAPLYTA.
Industry payments across IL — which companies pay providers there.
